Recent News

• 07.30.2025 - Sage Therapeutics Announces Second Quarter 2025 Financial Results
• 07.30.2025 - Sage Therapeutics Announces Second Quarter 2025 Financial Results
• 06.16.2025 - Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
• 06.16.2025 - Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio

Recent Filings

• 07.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.28.2025 - SC 14D9/A Solicitation, recommendation statements
• 07.28.2025 - SC TO-T/A Tender offer statement by Third Party
• 07.21.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 07.21.2025 - SC 14D9/A Solicitation, recommendation statements
• 07.02.2025 - SC 14D9 Solicitation, recommendation statements
• 07.02.2025 - SC TO-T Tender offer statement by Third Party
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.16.2025 - EX-99.1 EX-99.1